Task: Answer the multiple-choice question.
Query: Which compound exhibits a -3.002% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a. Cl.Clc1ccc2nsnc2c1NC1=NCCN1
b. CC(=O)Nc1ccc(NS(=O)(=O)c2ccc(OC(C)C(=O)N3CCOCC3)cc2)cc1
c. CCC1CN(C(=O)NCc2ccc(C)cc2)c2cc(C)ccc2O1
Answer: a. Cl.Clc1ccc2nsnc2c1NC1=NCCN1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cl.Clc1ccc2nsnc2c1NC1=NCCN1
Cl.Clc1ccc2nsnc2c1NC1=NCCN1
5-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-2,1,3-benzothiadiazol-4-amine;hydrochloride